Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...
661 Views
Concord Biotech (Pre-IPO): Niche Offering Amid Lean Competition to Drive Stable Growth
The IPO consists of offer for sale of 21M shares by Helix Investment Holdings at a price band of INR705–741/share. Through this IPO, Concord seeks...
292 Views
Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
Through capacity and capability addition in biologics manufacturing and expansion of commercial API manufacturing, Syngene has expanded...
362 Views
Divi’s Laboratories - Miss in 2QFY23; Growth Factors to Face Softness over Medium Term
DIVI delivered an earnings miss in 2QFY23. Reduced traction in Custom Synthesis (CS), coupled with lower operating leverage resulted in an earnings...
342 Views
Piramal Enterprises (PIEL IN): Demerger to Create a Differentiated and Niche Pharmaceutical Business
Shareholders’ nod for the proposed demerger will create pharmaceutical-focused listed entity, which should pave the way for value unlocking due to...
363 Views